相似文献
1
Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?
Br J Cancer Suppl. 1994 Sep;23:S54-5.
2
Diagnostic and therapeutic evaluation of an anti-Langerhans cell histiocytosis monoclonal antibody (NA1/34) in a new xenograft model.
J Invest Dermatol. 2000 Jan;114(1):127-34. doi: 10.1046/j.1523-1747.2000.00831.x.
3
Successful in vivo immunolocalization of Langerhans cell histiocytosis with use of a monoclonal antibody, NA1/34.
J Pediatr. 1994 Nov;125(5 Pt 1):717-22. doi: 10.1016/s0022-3476(94)70063-x.
4
Pathology of Langerhans cell histiocytosis.
Hematol Oncol Clin North Am. 1987 Mar;1(1):75-97.
5
6
Monoclonal antibody against histiocytosis X cells.
Histol Histopathol. 1992 Jul;7(3):405-13.
7
Langerhans cell histiocytosis of the hypothalamus: diagnostic value of immunohistochemistry.
Clin Neuropathol. 1996 Mar-Apr;15(2):87-91.
8
[Value of correlated immunofluorescence and immunoperoxidase study of monoclonal markers in 2 adult cases of histiocytosis X].
Ann Dermatol Venereol. 1984;111(1):31-6.
9
The scientific challenge of Langerhans cell histiocytosis.
Br J Cancer Suppl. 1994 Sep;23:S61-3.
10
Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
J Pathol. 2007 Jun;212(2):188-97. doi: 10.1002/path.2167.
引用本文的文献
1
Langerhans Cell Histiocytosis of the Mandible.
Cureus. 2022 Aug 21;14(8):e28222. doi: 10.7759/cureus.28222. eCollection 2022 Aug.
2
Langerhans cell histiocytosis at L5 vertebra treated with en bloc vertebral resection: a case report.
World J Surg Oncol. 2018 May 22;16(1):96. doi: 10.1186/s12957-018-1399-1.
3
Management of polyostotic eosinophilic granuloma.
Dent Res J (Isfahan). 2012 Nov;9(6):821-5.
4
Intralesional corticosteroid therapy for mandibular Langerhans cell histiocytosis preserving the intralesional tooth germ.
Oral Maxillofac Surg. 2008 Jul;12(2):105-11. doi: 10.1007/s10006-008-0113-9.
5
Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement.
Pediatr Radiol. 2005 Feb;35(2):103-15. doi: 10.1007/s00247-004-1262-0. Epub 2004 Jul 28.
本文引用的文献
1
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
J Clin Oncol. 1993 Apr;11(4):738-50. doi: 10.1200/JCO.1993.11.4.738.
2
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Lancet. 1993 Jun 26;341(8861):1620-2. doi: 10.1016/0140-6736(93)90759-a.
3
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
N Engl J Med. 1993 Oct 21;329(17):1219-24. doi: 10.1056/NEJM199310213291702.
4
CD1 antibody immunolocalisation in Langerhans' cell histiocytosis.
Lancet. 1993 Aug 7;342(8867):367-8. doi: 10.1016/0140-6736(93)91510-s.
5
Current controversies. Histiocytosis-X.
Hematol Oncol Clin North Am. 1987 Mar;1(1):147-62.
6
Reshaping human antibodies for therapy.
Nature. 1988 Mar 24;332(6162):323-7. doi: 10.1038/332323a0.
7
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
J Immunol. 1987 May 15;138(10):3566-72.
8
Monoclonal-antibody therapy in systemic vasculitis.
N Engl J Med. 1990 Jul 26;323(4):250-4. doi: 10.1056/NEJM199007263230407.
9
Monoclonal antibody-based therapies of leukemia and lymphoma.
Blood. 1992 Aug 15;80(4):863-78.
10
Humanised monoclonal antibody therapy for rheumatoid arthritis.
Lancet. 1992 Sep 26;340(8822):748-52. doi: 10.1016/0140-6736(92)92294-p.
Zotero 插件